Orthofix Revenue Per Share from 2010 to 2024

OFIX Stock  USD 19.04  0.13  0.69%   
Orthofix Medical Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 14.20 in 2024. Revenue Per Share is the amount of revenue generated by Orthofix Medical per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
20.32823533
Current Value
14.2
Quarterly Volatility
6.35155122
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Orthofix Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orthofix Medical's main balance sheet or income statement drivers, such as Interest Expense of 9.1 M, Total Revenue of 784 M or Gross Profit of 259.2 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0 or PTB Ratio of 0.79. Orthofix financial statements analysis is a perfect complement when working with Orthofix Medical Valuation or Volatility modules.
  
Check out the analysis of Orthofix Medical Correlation against competitors.
For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.

Latest Orthofix Medical's Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of Orthofix Medical over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Orthofix Medical's Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Orthofix Medical's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 20.77810 Years Trend
Very volatile
   Revenue Per Share   
       Timeline  

Orthofix Revenue Per Share Regression Statistics

Arithmetic Mean21.36
Geometric Mean19.31
Coefficient Of Variation29.74
Mean Deviation3.69
Median22.59
Standard Deviation6.35
Sample Variance40.34
Range29.3962
R-Value0.06
Mean Square Error43.31
R-Squared0
Significance0.84
Slope0.08
Total Sum of Squares564.79

Orthofix Revenue Per Share History

2024 14.2
2023 20.33
2022 22.97
2021 23.59
2019 24.33
2018 24.5
2017 23.95

About Orthofix Medical Financial Statements

Orthofix Medical investors use historical fundamental indicators, such as Orthofix Medical's Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Orthofix Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 20.33  14.20 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.